Skip to main content
. 2013 Jun 12;33(24):10182–10190. doi: 10.1523/JNEUROSCI.0284-13.2013

Table 2.

Behavioral data in Val/Val and Met carriers (mean ± SD)

Number of trials (of 45)
Initial testing
Delayed testing
Val/Val (n = 14) Met carriers (n = 15) Val/Val (n = 14) Met carriers (n = 15)
RH 14.1 ± 8.7 11.5 ± 4.9 13.4 ± 8.9 13.1 ± 4.7
KH 15.1 ± 5.8 15.6 ± 5.6 13.2 ± 4.4 11.0 ± 4.4
GH 10.3 ± 4.8 11.3 ± 3.2 11.8 ± 5.4 13.4 ± 4.2
MI 5.4 ± 4 6.3 ± 3.4 6.5 ± 4.4 7.5 ± 4.1
CR 31.3 ± 7.7 28.1 ± 4.7 38.8 ± 5.5 35.3 ± 5.3
FA 13.3 ± 7.6 16.3 ± 4.7 6 ± 5.3 9.7 ± 5.3
d′ 2.0 ± 0.7 1.5 ± 0.4 2.6 ± 0.9 1.9 ± 0.5
Criterion −0.4 ± 0.6 −0.4 ± 0.3 0.03 ± 0.6 −0.1 ± 0.3
HHS Vulnerability Disclosure